OrbiMed’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$25.7M Buy
2025
Q1
$31.3M Buy
2024
Q4
Sell
2024
Q3
$36.6M Sell
2024
Q2
$50M Buy
2024
Q1
$76.3M Buy
2023
Q4
$55.2M Sell
2023
Q3
$47.9M Buy
2023
Q2
$82.9M Hold
2023
Q1
$60M Buy
2020
Q2
Sell
2020
Q1
$1.35M Buy
2019
Q4
Sell
2019
Q3
$15M Sell
2019
Q2
$46.2M Buy
2019
Q1
$34.4M Buy
2018
Q4
$4.31M Buy